Guest guest Posted August 19, 2001 Report Share Posted August 19, 2001 I was just perusing the highlights of the 12th International Thyroid Congress. I came across the following: In most centers, the duration of antithyroid drug therapy averages between 1 and 2 years, but some patients are treated for longer (or shorter) periods. Liu and colleagues[31] examined the effect of duration of treatment on remission rates and TSH receptor antibody titers. A higher relapse rate was seen in patients treated for only 6 months, but 36 months of treatment appeared to offer no advantage over 18 months of treatment. Although there was a reciprocal relationship between TSH-receptor titers and duration of therapy, with the lowest levels seen after 36 months, the authors suggest that treatment for longer than 18 months should not be necessary. Now, I see that it is no wonder our doctors ore so confused and uninformed on this type of thing. The article above makes 2 contradictory statements. It's like the researcher wanted to show that using ATDs beyond 18 months was futile. His data disproved that, but he stuck by his original thesis anyway! Amazing. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.